Search

Search Results
Results 1 - 10 of 87 for multiple sclerosis
  • Drug - 1 Apr 2025
    Consumer Medicine Information (CMI) about Ocrevus intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Mayzent intended for persons living in Australia.
  • Drug - 30 Sep 2024
    Consumer Medicine Information (CMI) about Kesimpta intended for persons living in Australia.
  • Drug - 4 Oct 2024
    Consumer Medicine Information (CMI) about Lemtrada intended for persons living in Australia.
  • Drug - 20 Mar 2025
    Consumer Medicine Information (CMI) about Zeposia intended for persons living in Australia.
  • Drug - 13 Jan 2025
    Consumer Medicine Information (CMI) about Dovato intended for persons living in Australia.
  • Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Glatiramer Acetate-Teva 40mg/mL intended for persons living in Australia.
  • Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Copaxone Pen intended for persons living in Australia.
  • Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Copaxone 40mg/mL intended for persons living in Australia.
  • Drug - 8 Nov 2024
    Consumer Medicine Information (CMI) about Tysabri intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.